PMC:7646269 / 1214-1471 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":49,"end":66},"obj":"Disease"},{"id":"T11","span":{"begin":141,"end":149},"obj":"Disease"},{"id":"T12","span":{"begin":187,"end":200},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0002041"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":207,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":202,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A9","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":168,"end":200},"obj":"Phenotype"},{"id":"T6","span":{"begin":202,"end":205},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}

{"project":"LitCovid-sentences","denotations":[{"id":"T20","span":{"begin":13,"end":24},"obj":"Sentence"},{"id":"T21","span":{"begin":25,"end":150},"obj":"Sentence"},{"id":"T22","span":{"begin":152,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}

{"project":"LitCovid-PubTator","denotations":[{"id":"53","span":{"begin":6,"end":10},"obj":"Disease"},{"id":"58","span":{"begin":127,"end":135},"obj":"Species"},{"id":"59","span":{"begin":56,"end":66},"obj":"Disease"},{"id":"60","span":{"begin":112,"end":126},"obj":"Disease"},{"id":"61","span":{"begin":141,"end":149},"obj":"Disease"},{"id":"80","span":{"begin":243,"end":251},"obj":"Species"},{"id":"86","span":{"begin":168,"end":200},"obj":"Disease"},{"id":"87","span":{"begin":228,"end":242},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D003643"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D007239"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"MESH:D016638"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:C000657245"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"Tax:9606"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:D055744"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ients died.\n\nConclusions\nVigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.\n\n1 INTRODUCTION\nInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in th"}